Trial Profile
Phase II Study of 99mTc-rhAnnexin V-128 Radionuclide Imaging in Patients With Clinical Suspicion or Confirmed Diagnosis of Spondyloarthritis (SpA)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2019
Price :
$35
*
At a glance
- Drugs Tc-99m annexin V 128 (Primary)
- Indications Spondylarthritis
- Focus Diagnostic use; Proof of concept
- Acronyms Annexin 03
- Sponsors Advanced Accelerator Applications
- 11 Mar 2019 Status changed from recruiting to discontinued.
- 14 Jan 2019 Planned End Date changed from 1 Feb 2019 to 1 Oct 2019.
- 14 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019.